Cite
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor
MLA
Qing Lan, et al. “A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor.” JNCI Cancer Spectrum, vol. 4, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....517fcd8b8a134b6811d7005de10ddd12&authtype=sso&custid=ns315887.
APA
Qing Lan, Mark P. Purdue, Nathaniel Rothman, Hormuzd A. Katki, Ruth M. Pfeiffer, Allan Hildesheim, Jonathan N. Hofmann, Joseph J. Shearer, Ligia A. Pinto, C. Ola Landgren, Rebecca Landy, Troy J. Kemp, Charlene McShane, & Loredana Santo. (2019). A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor. JNCI Cancer Spectrum, 4.
Chicago
Qing Lan, Mark P. Purdue, Nathaniel Rothman, Hormuzd A. Katki, Ruth M. Pfeiffer, Allan Hildesheim, Jonathan N. Hofmann, et al. 2019. “A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor.” JNCI Cancer Spectrum 4 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....517fcd8b8a134b6811d7005de10ddd12&authtype=sso&custid=ns315887.